Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373354 · ClinicalTrials.gov registry record
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
A clinical trial of Architectural Distortions and Breast Tomosynthesis, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06373354: Recruiting study of Architectural Distortions and Breast Tomosynthesis, sponsored by M.D. Anderson Cancer Center.
NCT06373354 is a study of Architectural Distortions and Breast Tomosynthesis that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373354, a study of Architectural Distortions and Breast Tomosynthesis, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.
Primary Outcome
ncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events
Conditions Studied
Interventions
- DEVICE Digital Breast Tomosynthesis (DBT)
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-18 |
| Est. Completion | 2027-12-31 |
What NCT06373354 shows while recruiting
NCT06373354 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Architectural Distortions appearing as the primary indexed condition, and to 1 intervention - of which Digital Breast Tomosynthesis (DBT) is the first listed.
NCT06373354 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06373354 about?
NCT06373354 is a clinical study titled "Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems". To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.
What is the current status of trial NCT06373354?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-10-18. Estimated completion is 2027-12-31.
What conditions does trial NCT06373354 study?
This clinical trial studies the following conditions: Architectural Distortions, Breast Tomosynthesis.
What interventions are being tested in trial NCT06373354?
The interventions under investigation include: Digital Breast Tomosynthesis (DBT) (DEVICE).
Who is sponsoring clinical trial NCT06373354?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373354 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI